A new report from the European Commission has found that active competition law enforcement renders medicines more affordable and inspires innovation.
The report, compiled in collaboration between the competition authorities of all 28 EU Member States, provides an overview of the rules governing mergers, antitrust, and competition in the pharmaceutical sector since 2009, when an inquiry conducted by the Commission found that further action was needed to address product exclusivity in the industry. It will form the basis for future competition enforcement priorities in the sector.
By exerting judicious control of industrial mergers, antitrust rules, and safeguarding prices, the report found, the EU’s pharmaceutical competition enforcement bodies were able to discourage practices which disincentivize innovation, such as forcibly delaying the entry into market of generic drugs. By preventing cross-business transactions which could compromise research and development or the creation of new medicines, authorities contributed not only to the range of innovation present in the sector, but also to an increased level of patient choice.
Since 2009 the European Commission and national competition enforcement authorities across the EU have investigated more than 100 cases of suspected unlawful practices
Margrethe Vestager said, “Giving European patients and healthcare systems access to affordable and innovative medicines is one of Europe’s main challenges and objectives. The report published today provides key insights into the valuable work that competition authorities across Europe are doing to ensure that pharmaceutical markets help achieve this goal. It is important that we continue giving a high priority to our work in this area.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google and South Carolina Clash Over State Records Demand
May 8, 2024 by
CPI
Telefonica Germany Teams Up with Amazon Web Services to Migrate 5G Customers
May 8, 2024 by
CPI
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI